Dasatinib‐induced hypoglycemia in a patient with acute lymphoblastic leukemia

Tyrosine kinase inhibitors can cause significant hypoglycemia in patients with diabetes on other antihyperglycemic medications. These patients should be monitored, and their medications adjusted accordingly.

Detalles Bibliográficos
Autores principales: Lundholm, Michelle D., Charnogursky, Gerald A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364065/
https://www.ncbi.nlm.nih.gov/pubmed/32695366
http://dx.doi.org/10.1002/ccr3.2901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364065/
https://www.ncbi.nlm.nih.gov/pubmed/32695366
http://dx.doi.org/10.1002/ccr3.2901

Ejemplares similares